TY - JOUR
T1 - Pattern of neurotoxicity of n-hexane, methyl n-butyl ketone, 2,5-hexanediol, and 2,5-hexanedione alone and in combination with o-ethyl O-4-nitrophenyl phenylphosphonothioate in hens
AU - Abou-Donia, Mohamed B.
AU - Makkawy, H. M.
AU - Campbell, Gerald M.
N1 - Funding Information:
This study was supported in part by National Institute of Environmental Health Science grant 0H00823. The supply of technical EPN by E. I. DuPont De Nemours is acknowledged. Present address for H. M. Makkawy is School of Dentistry, Columbia University, New York, New York. Present address for G. M. Campbell is Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710. Requests for reprints should be sent to M. B. Abou-Donia, Department of Pharmacology, P.O. Box 3813, Duke University Medical Center, Durham, North Carolina 27710.
PY - 1985/1/1
Y1 - 1985/1/1
N2 - This investigation was designed to study the neurotoxicity produced in hens by the aliphatic hexacarbons n-hexane, methyl n-butyl ketone (MnBK), 2,5-hexanediol (2,5- HDOH), and 2,5-hexanedione (2,5-HD) following daily dermal application of each chemical alone and in combination with O-ethyl O-4-nitrophenyl phenylphosphonothioote (EPN). Dermal application was carried out on the unprotected back of the neck. To assess whether the joint neurotoxic action of various chemicals is caused by the enhancement of absorption through the skin or by interaction at the molecular level, two additional experiments were performed. In the first experiment, EPN was dissolved in each of the aliphatic hydrocarbons prior to their topical application. In the second experiment, EPN was dissolved in acetone and applied at a different location from that of the aliphatic hexacarbons. Dermal application was carried out for 90 d followed by a 30-d observation period. The results show that (1) hens treated with EPN developed severe ataxia followed by improvement during the observation period; (2) n-hexane produced leg weakness with subsequent recovery, whereas the same dose of MnBK, 2,5-HDOH, or 2,5-HD produced clinical signs of neurotoxicity characterized by gross ataxia; (3) concurrent dermal application of EPN with n-hexane or 2,5-HDOH at the same site or at different sites produced an additive neurotoxic action; (4) simultaneous dermal application of EPN and MnBK at different sites resulted in an additive effect, whereas it caused potentiation when applied at the same site; and (5) concurrent topical application of EPN and 2,5-HD produced a potentiating neurotoxic effect. While no histopathologic lesion was produced at the end of the observation period when any test chemical was applied alone, binary treatments of EPN and aliphatic hexacarbons resulted in histopathologic changes in some hens, with morphology and distribution characteristic of EPN neurotoxicity. The joint potentiating or additive action of aliphatic hexacarbons on EPN neurotoxicity was: 2,5-HD < MnBK < 2,5- HDOH < n-hexane. The mechanism of this joint action seems to be related both to enhancing skin absorption of EPN and/or to its metabolic activation by n-hexane and its related chemicals.
AB - This investigation was designed to study the neurotoxicity produced in hens by the aliphatic hexacarbons n-hexane, methyl n-butyl ketone (MnBK), 2,5-hexanediol (2,5- HDOH), and 2,5-hexanedione (2,5-HD) following daily dermal application of each chemical alone and in combination with O-ethyl O-4-nitrophenyl phenylphosphonothioote (EPN). Dermal application was carried out on the unprotected back of the neck. To assess whether the joint neurotoxic action of various chemicals is caused by the enhancement of absorption through the skin or by interaction at the molecular level, two additional experiments were performed. In the first experiment, EPN was dissolved in each of the aliphatic hydrocarbons prior to their topical application. In the second experiment, EPN was dissolved in acetone and applied at a different location from that of the aliphatic hexacarbons. Dermal application was carried out for 90 d followed by a 30-d observation period. The results show that (1) hens treated with EPN developed severe ataxia followed by improvement during the observation period; (2) n-hexane produced leg weakness with subsequent recovery, whereas the same dose of MnBK, 2,5-HDOH, or 2,5-HD produced clinical signs of neurotoxicity characterized by gross ataxia; (3) concurrent dermal application of EPN with n-hexane or 2,5-HDOH at the same site or at different sites produced an additive neurotoxic action; (4) simultaneous dermal application of EPN and MnBK at different sites resulted in an additive effect, whereas it caused potentiation when applied at the same site; and (5) concurrent topical application of EPN and 2,5-HD produced a potentiating neurotoxic effect. While no histopathologic lesion was produced at the end of the observation period when any test chemical was applied alone, binary treatments of EPN and aliphatic hexacarbons resulted in histopathologic changes in some hens, with morphology and distribution characteristic of EPN neurotoxicity. The joint potentiating or additive action of aliphatic hexacarbons on EPN neurotoxicity was: 2,5-HD < MnBK < 2,5- HDOH < n-hexane. The mechanism of this joint action seems to be related both to enhancing skin absorption of EPN and/or to its metabolic activation by n-hexane and its related chemicals.
UR - http://www.scopus.com/inward/record.url?scp=0022353337&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022353337&partnerID=8YFLogxK
U2 - 10.1080/15287398509530721
DO - 10.1080/15287398509530721
M3 - Article
C2 - 4068058
AN - SCOPUS:0022353337
SN - 0098-4108
VL - 16
SP - 85
EP - 100
JO - Journal of Toxicology and Environmental Health
JF - Journal of Toxicology and Environmental Health
IS - 1
ER -